Why the study?
Do NOS2 promoter polymorphisms correlate with malaria disease severity and NO production in Tanzanian children?
Do NOS2 promoter polymorphisms correlate with malaria disease severity and NO production in Tanzanian children?
Answers are grounded in this paper and cite their sources.
NOS2 promoter polymorphisms were not associated with malaria severity or NO production in Tanzanian children, highlighting population-specific differences in host resistance.
Nitric oxide (NO) plays an important role in host resistance to infection with a variety of organisms. Two recent reports from Gabon and Gambia identified associations of malaria disease severity with the inducible NO synthase (NOS2) promoter G-954C and short allele (<11 repeats) pentanucleotide microsatellite polymorphisms, respectively. It was postulated that there would be a correlation of these polymorphisms with malaria disease severity and with measures of NO production in our cohort of Tanzanian children with malaria. In Tanzanian children, 15% were heterozygous or homozygous for the G-954C polymorphism, and 13% had the short-allele microsatellite polymorphism. There was no significant correlation of either polymorphism with disease severity or with measures of NO production and NOS2 expression. Black and white Americans differed significantly in the frequencies of these polymorphisms. The various association of these gene polymorphisms with malaria severity in different populations underscores the complexity of host resistance to malaria.
No takes yet. Share an insight, caveat, or question.
Levesque et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: